sodium chloride injection bp 0.9%
fresenius kabi new zealand limited - sodium chloride 0.9%; ; - solution for injection - 0.9 % - active: sodium chloride 0.9% excipient: hydrochloric acid sodium hydroxide water for injection - sodium chloride injection bp 0.9% can be used as the vehicle for the restoration of electrolytes, as the vehicle for parenteral drug administration or as a sterile irrigation medium.
sodium chloride 0.9% freeflex sodium chloride 2.25 g/250 ml injection bag
fresenius kabi australia pty ltd - sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - normal saline can be used as a vehicle for many parenteral drugs and as an electrolyte replenisher for maintenance or replacement of deficits of extracellular fluid. it can also be used as a sterile irrigation medium.
sodium chloride injection, solution
fresenius kabi usa, llc - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - sodium chloride 9 mg in 1 ml - intravenous solutions containing sodium chloride are indicated for parenteral replenishment of fluid and sodium chloride as required by the clinical condition of the patient. none known. check flexible container solution composition, lot number, and expiry date. do not remove solution container from its overwrap until immediately before use. use sterile equipment and aseptic technique. to open - turn solution container over so that the text is face down. using the pre-cut corner tabs, peel open the overwrap and remove solution container. - check the solution container for leaks by squeezing firmly. if leaks are found, or if the seal is not intact, discard the solution. - do not use if the solution is cloudy or a precipitate is present. to add medication - identify white additive port with arrow pointing toward container. - immediately before injecting additives, break off white additive port cap with the arrow pointing toward container. - hold base of white additive port horizontally. - insert needle horizont
sodium chloride 0.9% w/v solution for infusion
fresenius kabi deutschland gmbh - sodium chloride - solution for infusion - 0.9 percent weight/volume - sodium chloride
sodium chloride 0.9%w/v solution for infusion
fresenius kabi deutschland gmbh - sodium chloride - solution for infusion - 0.9 percent weight/volume - sodium chloride
sodium chloride 0.9% w/v solution for infusion
fresenius kabi deutschland gmbh - sodium chloride - solution for infusion - 0.9 percent weight/volume - sodium chloride
sodium chloride 0.9% freeflex
fresenius kabi new zealand limited - sodium chloride 9 g/l; ; ; ; ; - solution for infusion - 0.9 % - active: sodium chloride 9 g/l excipient: hydrochloric acid sodium hydroxide water for injection - for the restoration and maintenance of salt and extracellular fluid levels or as a vehicle for the administration of parenteral drugs.
sodium chloride 0.9% 4.5g/500ml injection bag
fresenius kabi australia pty ltd - sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - normal saline can be used as the vehicle for many parenteral drugs and as an electrolyte replenisher for maintenance or replacement of deficits of extracellular fluid.
epirubicin kabi epirubicin hydrochloride 10 mg/5 ml solution for injection vial
fresenius kabi australia pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - epirubicin hydrochloride has produced responses in a wide spectrum of neoplastic diseases and is indicated for the treatment of:,? breast cancer,? gastric cancer,? ovarian cancer,? small cell lung cancer,? lymphoma (non-hodgkin?s lymphoma),? advanced/metastatic soft tissue sarcoma,? superficial bladder cancer (tis; ta).,in bladder cancer, epirubicin hydrochloride is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grade 2 and 3).
epirubicin kabi epirubicin hydrochloride 200 mg/100 ml solution for injection vial
fresenius kabi australia pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium chloride - epirubicin hydrochloride has produced responses in a wide spectrum of neoplastic diseases and is indicated for the treatment of:,? breast cancer,? gastric cancer,? ovarian cancer,? small cell lung cancer,? lymphoma (non-hodgkin?s lymphoma),? advanced/metastatic soft tissue sarcoma,? superficial bladder cancer (tis; ta).,in bladder cancer, epirubicin hydrochloride is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grade 2 and 3).